Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-023349
Filing Date
2023-06-23
Accepted
2023-06-23 17:16:47
Documents
3
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1687554994.html 3  
1 FORM 3 wk-form3_1687554994.xml 3 2319
2 EX-24 powerofattorney_gallaghe.htm EX-24 3519
3 powerofattorney_gallaghe001.jpg GRAPHIC 193045
  Complete submission text file 0001628280-23-023349.txt   273162
Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Gallagher Carol Giltner (Reporting) CIK: 0001329959 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 231038692

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations